Avandia (rosiglitazone) is a drug manufacture by GlaxoSmithKline used in the treatment of type 2 diabetes. The diabetes drug Avandia has been known to increase the risk of heart attack. To date, there have been 100,000 heart attacks recorded as being linked to the use of the diabetes drug Avandia. These occurrences of heart attacks resulting from Avandia use were documented by a scientist at the U.S. Food and Drug Administration (FDA).
The injurious effect Avandia has on cardiovascular health has put the FDA and the medical community on alert. Side effects and risks of taking the diabetes drug Avandia or any other drug containing rosiglitazone include the following:
Studies conducted on the health effects of Avandia use in type 2 diabetes patients also found the increased risk of suffering a bone fracture. This incidence of bone fractures, especially those occurring in the upper arms, was released in data collected by GlaxoSmithKline during their Avandia research. The manufacturer of Avandia also noted that bone fractures were more likely to occur in female patients.
Increased cardiovascular risks linked to Avandia usage:
The following list describes common Avandia side effects. Please note that the list does not include all potential Avandia side effects:
FDA Approval: May 25, 1999 for controlling blood sugar levels in type II diabetics
Generic Availability: N/A
Pregnancy Risk: Category C